Bellerophon Therapeutics Inc (BLPH): Had a pre-planned sale price of $.68 and...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Bellerophon Therapeutics Inc (BLPH)

Reply Private New

Keep Last Read

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	6
Posts	1924
Boards Moderated	0
Alias Born	09/26/2007

Re: None

Sunday, 01/15/2017 2:16:41 AM

Sunday, January 15, 2017 2:16:41 AM

Had a pre-planned sale price of $.68 and when I woke up, I realized I no longer owned BLPH. So now I have to hope for a little fall so I can buy back in. Still, can't argue with a 17% profit.

My second profitable trade on this stock in the last two weeks. Other stocks are down so this helps a little bit.

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent BLPH News

Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 02:29:00 PM
Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/26/2024 07:31:31 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/26/2024 03:46:43 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 08:21:55 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 09:05:20 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/03/2024 06:49:05 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/27/2023 02:50:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2023 12:51:41 AM
Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 10/16/2023 05:59:54 PM
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 10/16/2023 05:59:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 02:30:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 12:45:13 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:30:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2023 08:05:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2023 08:10:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/20/2023 08:05:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/14/2023 08:05:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/29/2023 08:06:11 PM

More BLPH News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow